A study published online at ATSJournals.org reviewed pertinent literature to further explore the effects of inhaled corticosteroids on incident pneumonia and mortality in patients with COPD.
“Despite the robust association of inhaled corticosteroid use with increased risk of pneumonia, all studies find either no difference or a reduction in pulmonary-related and overall mortality associated with the use of inhaled corticosteroids,” the authors concluded.
- Disorders & Diseases
- Public Health
- Products & Treatment
- Department Management